Dec 13, 09:07
52 Week HighWyeth has hit a 52wk high of Rs 1,007.35 on NSE
52 Week HighWyeth has hit a 52wk high of Rs 985.00 on NSE
AnnouncementsWyeth, Pfizer to merge, creating a single Pfizer brand
AnnouncementsWyeth fixes record date for interim dividend
AnnouncementsWyeth approves 1450% interim dividend
Only BuyersOnly Buyers in Wyeth on NSE
AnnouncementsWyeth to consider interim dividend
AnnouncementsWyeth: Updates on outcome of AGM
|Company Name||Last Price||%
|Dr Reddys Labs||2403.55||-0.01||2545.00||1764.00||40,884.32|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
Wyeth is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,735.81 crore.The company has reported a standalone sales of Rs 171.37 crore and a Net Profit of Rs 18.38 crore for the quarter ended Sep 2013.
The company management includes Pradip Shah - Chairman, Darius Udwadia - Director, Sunil Lalbhai - Director, Sekhar Natarajan - Director, Vivek Dhariwal - Director, S Sridhar - Director.
It is listed on the BSE with a BSE Code of 500095 and the NSE with an NSE Code of WYETH.
Its Registered office is at Level 6, Platina, 'Plot No C - 59, 'G' Block,',Bandra - Kurla Complex, Mumbai,Maharashtra - 400098.
Their Registrars are Karvy Computershare Private Ltd.